Managing Partner
Aaron McKeon-Fish has over 15 years of experience within biotechnology and life science industry, serving as a thought partner and support strategy development for life sciences organizations across a breadth of therapeutic areas, including oncology, immunology, neurology, cardiology & rare disease. Areas of expertise include pricing & contracting, channel economics, launch excellence playbooks, loss of exclusivity/biosimilar channel targeting & positioning. His deep expertise in competitive scenario planning has supported many clients’ GTM strategies aligned to optimizing patient access.
Aaron holds a B.S. in biochemistry from The College of New Jersey, and an M.B.A (strategy, management) from New York University Stern School of Business. Prior to joining TDG, Aaron worked in life sciences strategy consulting at McCann Health and in early stage oncology/ hematology drug discovery at The Children’s Hospital of Philadelphia.
Managing Partner
Sophia Tan has over 15 years of experience in the biotechnology and life sciences industry, specialized in market access and commercial strategy with in-depth expertise in clinical pathways, value-based care, and precision medicine. She has been a thought partner for numerous biopharma clients, providing strategic advice on a wide array of issues including clinical pathway strategy and operational planning, payer and provider channel engagement, go-to-market strategy, and value-based care.
Prior to joining TDG, Sophia received her doctoral degree and led clinical research on neural stem cells at Weill Cornell and Memorial Sloan-Kettering. Her research has been presented at international conferences and published in top peer-reviewed journals.
Managing Partner
Jen Klarer has over a decade of experience in multi-channel market analysis and strategic access optimization, spanning specialty therapeutic categories including cell and gene therapy, oncology, immunology, and rare disease. Areas of differentiated expertise include coverage and reimbursement modeling, provider site activation planning and commercial operations configuration (distribution, patient services, and field team execution) to optimize patient reach.
Jen has a Bachelor of Arts in chemistry from Franklin & Marshall College and a Master of Science in biomedical engineering from Columbia University. Prior to joining TDG, she conducted six years of academic research, including pre-clinical study of an autologous cell therapy for critical limb ischemia.
Managing Partner
James Pisano has extensive experience across specialty therapeutic classes including immunology, neuroscience, ultra-rare disease, and women’s health. Areas of particular focus include economic modeling, deconstructing evolution in stakeholder business models, and mapping influence across customers.
James studied biomedical engineering & economics, earning a bachelor’s degree from Northwestern University. During his time at Northwestern, he conducted research on the physiological implications of ischemic stroke.
Managing Partner
Matthew Cunningham has broad experience in oncology provider model evolution, precision medicine & population health strategies. Matt has supported provider channel engagement strategies for dozens of oncology brands and continues to work with many clients in the development of key account / field team infrastructure and targeting strategies.
Matt studied healthcare management & policy, earning his bachelor’s degree from Georgetown University, and has administrative experience at both an NCI-accredited cancer center and a community oncology practice.
Partner
Sachin Purwar brings over 20 years of biopharma and life sciences commercialization experience to The Dedham Group, with a focus on commercial and portfolio strategy, launch excellence, opportunity assessments, forecasting, and corporate development. He supports organizations across several therapeutic areas, including oncology, neurology, rare diseases, immunology, and women’s health.
Prior to joining TDG, he was a managing director at Trinity Life Sciences and Syneos Health Consulting. Sachin also held positions at Kraft Foods, Blott Asset Management, and Pfizer, where he was a specialty sales representative serving the urology, cardiovascular, endocrine, OB/GYN, and respiratory markets.
Sachin holds an MBA from Columbia Business School and a BS in biochemistry and molecular biology from The Pennsylvania State University.
VP, Business Operations
As Dedham’s VP, Business Operations, Dave Sauchelli is responsible for overseeing the firm’s finance and business operations functions, including FP&A, human resources, contracting, and systems integrations/implementations.
Dave joined Dedham in 2013 and works to develop strategic business and accelerated growth plans alongside the partners.
With over 15 years of professional experience, he began his career at Prudential Financial helping individuals and institutions improve their financial wellness. Dave studied finance, earning his bachelor’s degree from New Jersey City University.
